Skip to content

MOTO Post-marketing Surveillance Study

MOTO MEDIAL UNICOMPARTMENTAL KNEE ARTHROPLASTY: OPEN, PROSPECTIVE, MULTICENTRIC, OBSERVATIONAL STUDY

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04072055
Enrollment
150
Registered
2019-08-28
Start date
2019-09-25
Completion date
2023-03-16
Last updated
2023-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteo Arthritis Knee, Osteonecrosis

Keywords

Unicompartmental Knee Arthroplasty, UKA, antomic femoral component, anatomic tibial component

Brief summary

The prospective, multicentric, observational study has the aims to monitor the performance of the MOTO medial unicompartmental knee system in the treatment of patients with knee disease requiring a UKA. 150 patients will be recruited in 18 months and will be reviewed until 5 years follow-up visit after surgery. The primary objective of the study is to evaluate the prosthesis survival at 5 years.

Interventions

DEVICEMOTO Medial

MOTO medial unicompartmental knee system

Sponsors

Medacta International SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with unicompartmental tibiofemoral osteoarthritis (OA) of the knee that meet the indications for use of Medacta implant included in this study (on-label use); * Patients suffering from unilateral osteoarthritis or osteonecrosis of a single knee compartment; * Frontal deformity \< 10° (evaluated on weight-bearing long-axis x-rays); * Flexion contracture \< 10°; * Intact ligaments; * Patients willing and able to provide written informed consent for participation in the study; * Patient's age over 18 years old; * Patient with BMI \< 40 kg/m2; * Patients willing to comply with the pre and post-operative evaluation schedule.

Exclusion criteria

* Patients with one or more medical conditions identified as a contraindication in the labelling on any Medacta implants used in this study; * Any patient who cannot or will not provide informed consent for participation in the study; * Patients who need a revision surgery; * Patients who had previously undergone high tibial osteotomy or anterior cruciate ligament (ACL) reconstruction; * Patients with BMI ≥ 40 kg/m2; * Patients unable to understand and take action; * Any case not described in the inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Prosthesis survival5 yearssurvivorship analysis according to Kaplan-Meier method at 5 years after surgery

Secondary

MeasureTime frameDescription
New Knee Society Score (KSS)preoperative, 3 months, 1, 3 and 5 yearsFunctionality and symptom of operated knee will be evaluated by New KSS score
Radiological analysispreoperative, postoperative, 3 months, 1, 3 and 5 yearsPostoperative stability and fixation of the device will be assessed by standard radiological exams
Complicationup to 5 yearsIntraoperative and postoperative complication will be collected during all duration of the study

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026